tiprankstipranks
Trending News
More News >
BioMark Diagnostics (TSE:BUX)
:BUX
Canadian Market

BioMark Diagnostics (BUX) Cash flow

Compare
3 Followers

BioMark Diagnostics Cash Flow

TSE:BUX's free cash flow for Q2 2026 was C$-490.55K. For the 2026 fiscal year, TSE:BUX's free cash flow was decreased by C$-109.74K and operating cash flow was C$-481.83K. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 24Dec 22Dec 21Dec 20
Operating Cash Flow
C$ -1.09MC$ -982.52KC$ -914.42KC$ -1.20MC$ -455.55K
Investing Cash Flow
C$ -3.53KC$ -4.39KC$ -5.30KC$ -59.20KC$ -3.20K
Financing Cash Flow
C$ 3.42MC$ 1.07MC$ 609.05KC$ 768.16KC$ 724.63K
End Cash Position
C$ 2.48MC$ 156.75KC$ 72.04KC$ 382.71KC$ 877.68K
Free Cash Flow
C$ -1.10MC$ -986.91KC$ -919.72KC$ -1.26MC$ -455.55K
Currency in CAD

BioMark Diagnostics Cash Flow